Now Is The Time For Independent Industry Self-Regulation
When French drugmaker Sanofi SA and Danish pharmaceutical giant Novo Nordisk both announced last month that they will lower prices of their insulin products in the United States, close on the...To view the full article, register now.
Already a subscriber? Click here to view full article